title: Improved cadaveric renal transplant outcome in children.
abstract: We analyzed the results of 165 pediatric cadaver renal transplants performed at the University of California at Los Angeles to identify the factors which are linked to improved allograft survival. Both univariate life-table analysis and the Cox proportional hazard model were used. The use of a sequential immunosuppressive regimen (P less than 0.001) and kidneys from donors of more than 6 years of age (P less than 0.001) were found to be the factors having the most influence on primary graft survival. The sequential regimen was the only factor favorably influencing retransplants. With sequential therapy 1- and 2-year actuarial graft survival rates were 94% and 91% in primary transplants, and 82% and 70% in retransplants. Medication noncompliance exerted a large negative effect on transplant outcome. Of 70 recipients who had been on cyclosporine for at least 6 months, 50% evidenced noncompliance. Sixty-four percent of adolescents were noncompliant. Thirteen percent of the recipients lost their graft because of noncompliance. We conclude that good results can be obtained with cadaver renal transplants in children with a sequential immunosuppressive regimen and the use of kidneys from adolescent and adult donors. Noncompliance is a great barrier to long-term success in pediatric transplantation.
authors.affiliation: Department of Pediatrics, University of California, Los Angeles School of Medicine 90024.
authors.forename: R B
authors.initials: RB
authors.lastname: Ettenger
authors.forename: J T
authors.initials: JT
authors.lastname: Rosenthal
authors.forename: J L
authors.initials: JL
authors.lastname: Marik
authors.forename: M
authors.initials: M
authors.lastname: Malekzadeh
authors.forename: S B
authors.initials: SB
authors.lastname: Forsythe
authors.forename: E S
authors.initials: ES
authors.lastname: Kamil
authors.forename: I B
authors.initials: IB
authors.lastname: Salusky
authors.forename: R N
authors.initials: RN
authors.lastname: Fine
mesh_terms: D000293:Adolescent; D000328:Adult; D002102:Cadaver; D002648:Child; D003524:Cyclosporins / Q000008:administration & dosage; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D010349:Patient Compliance
chemical_list: D003524:Cyclosporins